Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,072

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

July 28, 2028

Conditions
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Interventions
DRUG

Huaier Granule

The subjects in the experimental group will be treated with Huaier Granule continuously for 2 years or until the disease progressed, intolerable toxicity, withdrawal of informed consent form or died for any reason.

Trial Locations (34)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

Unknown

RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

RECRUITING

The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei

RECRUITING

Cancer Hospital Chinese Academy of Medical Science, Beijing

RECRUITING

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

RECRUITING

The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital, Shijiazhuang

RECRUITING

The First Affiliates Hospital of Ha'erbin University, Harbin

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

RECRUITING

Tongji Medical College of HUST, Wuhan

RECRUITING

Union Hospital Tongji Medical College Huazhong Univeristy of Science and Technology, Wuhan

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

Jiangsu Province Hospital of Chinese Medicine, Nanjing

RECRUITING

Jiangsu Provincial Hospital, Nanjing

RECRUITING

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Northern Jiangsu People's Hospital, Yangzhou

RECRUITING

The Second Hospital of Jilin University, Changchun

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital), Xi’an

RECRUITING

The First Affiliatied Hospital Zhejiang University School of Medicine, Hangzhou

RECRUITING

The Second Affiliated Hospital Zhejiang Univerisity of Medicine, Hangzhou

RECRUITING

Huamei Hospital, University of Chinese Academy of Sciences, Ningbo

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

RECRUITING

The First School of Medicine, School of Information and Engineering,the First Affiliated Hospital of WMU, Wenzhou

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

collaborator

Huazhong University of Science and Technology

OTHER

lead

Fudan University

OTHER

NCT04790305 - Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer | Biotech Hunter | Biotech Hunter